Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.33 -0.12 (-0.51%)
As of: Nov 12, 2026 · 10:44 AM EST

Bright Minds Biosciences (DRUG) Cash from Investing Activities (2020)

Updated

Bright Minds Biosciences (DRUG) posted Cash from Investing Activities of -$17,546 for fiscal Q1 2021 (quarter ended Dec 31, 2020).

Analysis

Bright Minds Biosciences (DRUG) Cash from Investing Activities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -17,546.38
API Access

Bright Minds Biosciences Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=DRUG&period=max&api_key=YOUR_API_KEY